Liver cancer is the sixth most commonly diagnosed cancer worldwide and third-leading cause of cancer-related deaths in the United States.1,2 Hepatocellular carcinoma, or HCC, is the most common type of liver cancer, yet more than half of patients are diagnosed at advanced stages of the disease often when symptoms first begin to appear.3,4 Historically, the prognosis for advanced HCC has been poor, with only 7% of patients surviving up to five years after diagnosis.4

http://imfinzi.com/

But today, there is reason for optimism. Advances in research and medical innovation are signaling a shift in patient expectations, offering hope for more time for patients navigating their unresectable HCC or uHCC diagnosis. Here to explain the progress being made in the treatment landscape is Dr Shroff [shrawf] with the University of Arizona Cancer Center.

BIO:
Rachna T. Shroff, MD, MS, FASCO, is associate director of Clinical Investigations and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona Cancer Center (UACC). She also is a professor with tenure in the Department of Medicine, Chief of the Division of Hematology and Oncology, and Medical Director for the Oncology Service Line. Dr. Shroff also served as Associate Dean for Clinical and Translational Research for the University of Arizona College of Medicine – Tucson; 2021 – 2024. She came to UACC from MD Anderson Cancer Center in Houston, where she was on faculty from 2010-18 after completing her medical oncology fellowship there.
Research Interests
Dr. Shroff is a clinical and translational investigator focused on developing novel therapies for pancreatic and hepatobiliary cancers. She holds multiple positions nationally due to her expertise in these areas, including serving as the Hepatobiliary Subcommittee co-chair for the Southwest Oncology Group (SWOG) and as Chair for GI ASCO 2025, a meeting sponsored by the American Society of Clinical Oncology focused on gastrointestinal cancers. Most recently, she was elected to serve on the ASCO Nominating Committee. She also is a member of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation.

Dr. Shroff has led numerous clinical trials focusing on pancreaticobiliary tumors and is the national PI for SWOG 1815 which investigated a triplet chemotherapy regimen as a potential new standard of care for biliary cancers. This is based on a phase 2 study she led that is now published in JAMA Oncology. Dr. Shroff has been invited to speak at national and international meetings on topics related to targeted therapies for pancreatic and biliary cancers and has numerous peer-reviewed publications in this area.

#livercancer #cancer #drshroff #hcc #hepatocellularcarcinoma

The post Did you know October is Liver Cancer Awareness Month? appeared first on Good News!.

Designed to empower people with multiple myeloma (MM), MM Told True highlights the stories of those with the disease, bringing them to the forefront through spoken or visual art. In her thought-provoking poem, Jae tells the story of Oya – a committed father, podcaster, aspiring musician and advocate for health equity in the Black community – who was diagnosed with MM in 2017, despite difficulty having his concerns taken seriously.

Since his diagnosis, Oya has become an outspoken member of the MM community, with the hope that others will reach a quicker diagnosis and feel supported through treatment.

MM is a currently incurable cancer of plasma cells in the bone marrow with over 34,000 new cases estimated to be diagnosed in 2023. Even with treatment, the disease tends to relapse – meaning symptoms come back after temporarily improving – or progress.

Patients report feeling like they’re inside a maze, as promising treatment paths repeatedly hit a wall. MM disproportionately impacts ethnic and racial minority groups in incidence, onset and outcome, with Black patients twice as likely to die from the disease compared with white patients.

MM Told True not only illustrates patient stories, but also provides tools and information about MM – so people living with the disease can feel educated and empowered against this relentless blood cancer.

The next phase of the campaign involves encouraging others affected by MM to share their unique stories on MMToldTrue.com, whether it comes in the form of a personal photo, a powerful message or something else that expresses how they feel. These lived experiences can serve as inspiration for people with MM and their care partners.

On March 2, Oya and Jae will be available to discuss how they came together to create meaningful art from Oya’s story, his experience living with MM, and how others can share their own stories and find support through the MM Told True website.
Interview courtesy: Pfizer Inc.

The post March is Myeloma Action Month A NEW MULTIPLE MYELOMA (MM) CAMPAIGN “MM Told True” BRINGS PATIENT STORIES TO LIFE THROUGH ART appeared first on Good News!.

The 25th Annual Collaborating for a Cure Gala, one of New York City’s favorite charity events celebrated its silver anniversary at Cipriani Wall Street. The “fun-raiser as opposed to fundraiser” as described by Michael Nierenberg raised more than $6 million towards the goal of funding the next five years of crucial SWCRF cancer research programs such as the Partnership for Aging and Cancer Research Program, the SWCRF Institute Without WallsTM, and the Women’s Cancer Research Program.

Following a cocktail reception across the street, guests made their way to the main dining room where emcee, CBS’s Chris Wragge, welcomed the more than 700 guests, introduced the evening’s honorees, and highlighted many of the Foundation’s groundbreaking achievements over the past 50 years. “Tonight, we have a great program to celebrate two giants in the fight against cancer”, said Wragge.

Upon receiving the Vision and Leadership Award, SWCRF Board Chairman Michael Nierenberg commented, “The real honorees are Dr. Waxman and the great heroes like him who treat and cure cancer every day.”

Founder and CEO Dr. Samuel Waxman, who received the well-deserved and long-overdue Lifetime Achievement Award, spoke to his vision (goal) for a future in which cancer does not have to be a disease associated with aging. “The incidence of cancer is increasing, in part, as a by-product of improvements we are making in human longevity,” said Dr. Waxman. “But through our collaborative research programs, we can flatten this curve. I am thrilled to be a part of many amazing breakthroughs that have occurred in cancer research – with more to come.”

Special guest, author and breast cancer survivor, Musa Mayer, shared why she has been a longtime supporter of SWCRF and very generously offered a $1 million match for all donations made during the gala. “I will be celebrating my 80th birthday soon thanks to the work of this foundation and Dr. Samuel Waxman,” said Mayer.

As in previous years, the Collaborating for a Cure Gala included a live auction during the night’s festivities, including a meet and greet with MT. JOY, culinary experiences at the Cipriani Vault, il Buco Vita, and New York Vintners, and a Palm Bay Italian Winery experience (in Tuscany) to name a few. There was also a raffle for a private 7-day Bahamas cruise aboard an 82-foot, hybrid-powered, luxury yacht.

Notable attendees include SWCRF Board Chairman Michael Nierenberg, Founder and CEO Dr. Samuel Waxman, Gala Event Chairs, Spencer Waxman, Nicholas Santoro, Baron Silverstein, Marc Taub and Gala MC, Chris Wragge, Elin Nierenberg, Marion Waxman, Sandra Dugoff, Julie Waxman, Eliz Waxman, Jack Waxman, Sophia Bergan, Mario Pecoraro, Chris Arlotta, Mark D. Friedman, Jeremy Hoffman, Sara Waxman, Bettina Waxman, Scott Waxman, Bryan Griffin, Katya Tolstova, Nadja Sayej, William T. Sullivan, Erica Fineberg. Robin Lathrop, MT. JOY.

Known for its history of top-notch live performances, this year’s gala featured a live concert by MT. JOY.

For more information, visit www.waxmancancer.org/gala.

For selected high-resolutions images, visit: https://bit.ly/3XbltYB

(Photo credits: Jared Siskin PMC/Getty Images)

To view the Full Gallery of Images (Patrick McMullen): https://bit.ly/3OfqN9r

To view the Full Gallery of Images (Getty Images): https://bit.ly/3OikJwC

About The Samuel Waxman Cancer Research Foundation (SWCRF):

The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe. For more information about the SWCRF research, visit www.waxmancancer.org.

Facebook: WaxmanCancer https://www.facebook.com/WaxmanCancer

Instagram: @waxmancancer https://www.instagram.com/waxmancancer/

Twitter: @waxmancancer https://twitter.com/WaxmanCancer

PRESS CONTACT (SWCRF):

Norah Lawlor | Lawlor Media Group | www.lawlormediagroup.com

Norah@lawlormediagroup.com | Tel: (212) 967-6900

I: lawlormedia | T: @LawlorMedia | F: LawlorMediaGroup

Samuel Waxman, M.D., Marion Waxman (Photo Credit: Jared Siskin PMC/Getty Images)

Chris Wragge, Michael Nierenberg (Photo Credit: Jared Siskin PMC/Getty Images)

Gala MC Chris Wragge (Photo Credit: Jared Siskin PMC/Getty Images)

Bryan Griffin (Photo Credit: Jared Siskin PMC/Getty Images)

Katya Tolstova (Photo Credit: Jared Siskin PMC/Getty Images)

Nadja Sayej (Photo Credit: Jared Siskin PMC/Getty Images)

Lawlor Media Group, inc.

434 West 33rd Street

7th Floor

New York, NY

10001

United States of America

T: 212.967.6900 C: 917.774.1000

www.lawlormediagroup.com

This message is confidential. It may also be privileged or otherwise protected by work product immunity or other legal rules. If you have received it by mistake, please let us know by e-mail reply and delete it from your system; you may not copy this message or disclose its contents to anyone. The integrity and security of this message cannot be guaranteed on the Internet.

#samwaxman #samuelwaxman #cancer #curegala #newyorkcity #ny #nyc #samuelwaxmancancerresearchfoundation #swcrf #cipriani #wallstreet

The post Samuel Waxman Cancer Research Foundation 25th Annual Collaborating for a Cure Gala appeared first on Good News!.

Current research suggests that a reduction in breast cancer screenings at the beginning of the COVID-19 pandemic may have contributed to fewer early-stage and more late-stage breast cancer diagnoses in 2020 (latest statistics available) than in 2019, according to a study published by the journal JAMA Network Open.3

Many people experienced delayed or cancelled mammograms because of the pandemic, and these disruptions may have contributed to later-stage breast cancer diagnoses, when the disease is more difficult to treat.3,4

While mammography screenings rebounded overall by July 2020, the cumulative deficit of missed mammograms may have important public health consequences,5 including the furthering of health disparities.6

Since 2021, breast cancer diagnoses have exceeded lung cancer diagnoses, becoming the most diagnosed cancer worldwide.7,8

In the United States, it is estimated that about 287,850 women in 2022 will be diagnosed with breast cancer.9 Breast cancer is the most commonly diagnosed cancer among women in the U.S., and this year it’s estimated that about 30% of all newly diagnosed cancers in women will be breast cancers.10

For those facing a breast cancer diagnosis, the treatment that follows can be challenging and time consuming. Additionally, the type of breast cancer a patient has — including triple negative, HER2+ or HR+ — impacts the type of treatment they’ll receive.

Dr. Ahmed Elkhanany, a breast cancer expert at the University of Alabama at Birmingham, will discuss the latest news surrounding delays in breast cancer screenings and some of the recent treatment options. A patient share her experience too.

Interview courtesy: Genentech

1 American Cancer Society. American Cancer Society Recommendations for the Early Detection of Breast Cancer. https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html. Accessed June 9, 2022.
2 American Cancer Society. Survival Rates for Breast Cancer. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html. Accessed June 9, 2022.
3 Zhou J, et al. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic. JAMA Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789064. Accessed June 1, 2022.
4 Elek P, et al. Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. https://www.sciencedirect.com/science/article/pii/S0168851022001257?via%3Dihub. Accessed June 9, 2022.
5 Sprague B, et al. Changes in Mammography Utilization by Women’s Characteristics during the First 5 Months of the COVID- 19 Pandemic. JNCI. 29 March 2021. https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djab045/6184869.
Accessed June 1, 2022.
6 DeGroff A, et al. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States. Preventive Medicine. 2021. https://www.sciencedirect.com/science/article/pii/S0091743521001432?utm_campaign=11a0a4d458MR_COPY_02&utm_medium=email&utm_source=STAT+Newsletters&utm_term=0_8cab1d7961-11a0a4d458-153427414. Accessed June 1, 2022.
7 World Health Organization. Breast cancer now most common form of cancer: WHO taking action. https://www.who.int/news/item/03-02-2021-breast-cancer-now-most-common-form-of-cancer-who-taking-action. Accessed June 1, 2022.
8 International Agency for Research on Cancer. All-cancers fact-sheet. https://gco.iarc.fr/today/fact-sheets-cancers. Accessed June 10, 2022.
9 National Cancer Institute, The Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts: Female Breast Cancer. https://seer.cancer.gov/statfacts/html/breast.html. Accessed June 10, 2022.
10 BreastCancer.org. U.S Breast Cancer Statistics. https://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed June 10, 2022.

#breastcancer #ahmedelkhanany #pandemic #melissa #women #survivalrates #covid #delayed #cancelmammograms #cancelledmammograms #disruptions #genentech #screening #treatment #experience

The post DROP IN EARLY BREAST CANCER DIAGNOSES TIED TO PANDEMIC appeared first on Good News!.

Iconic Summer Event Raises $400,000 For Cancer Research

Cristian Notari, CEO Max Mara USA, Mark Melchiorre, Bess Freedman, Dr. Samuel Waxman, SWCRF Founder and CEO, Chef Julian Medina, William T. Sullivan, SWCRF Executive Director

(photo credit ©Patrick McMullan)

Honorees:

Bess Freedman, CEO of Brown Harris Stevens, Distinguished Business Leader Award Mark Melchiorre, Executive Managing Director, CIO & Head of Brean Investment Group, Distinguished Finance Leader Award Chef Julian Medina, Chef & Owner of Toloache, Coppelia, Tacuba, La Chula, El Fish Shack and Kuxe Hospitality and Service Award Max Mara USA, Fashion Cares Award

More than 300 guests attended the Samuel Waxman Cancer Research Foundation’s 18th Annual Hamptons Happening, one of the Hamptons’ most-anticipated summer social events. Hosted on the beautiful Bridgehampton estate of Kenneth and Maria Fishel, the beloved event raised $400,000 for groundbreaking cancer research.

“Over the past 18 years, the Hamptons Happening has raised nearly $6 million for cancer research and with this year’s event we have surpassed that amazing milestone,” said William T. Sullivan, SWCRF executive director. “Since its founding, SWCRF has invested more $100 million towards collaborative cancer research, contributing to a number of scientific breakthroughs in the fight to eradicate cancer.”

This year’s event honored Bess Freedman, CEO of Brown Harris Stevens, for the Distinguished Business Leader Award; Mark Melchiorre, Executive Managing Director, CIO & Head of Brean Investment Group with the Distinguished Finance Leader Award; Chef Julian Medina, Chef-Owner of Toloache, Coppelia, Tacuba, La Chula, El Fish Shack and Kuxe with the Hospitality and Service Award; and Max Mara with the Fashion Cares Award.

“Cancer has affected all of us in one way or another. We know the struggles of the disease and pervasiveness firsthand. The Samuel Waxman Cancer Research Foundation has one mission: eradicate cancer. I am honored to be able to participate and contribute to this unparalleled organization and such a worthy cause,” said Bess Freedman CEO of Brown Harris Stevens, recipient of the SWCRF 2022 Distinguished Business Leader Award.

“Cancer has touched our family many times. My mother, aunts, uncles, and sister-in-law have all suffered various cancer diagnoses. As a result, our family is very involved in volunteering our time and resources to support cancer research. The Waxman Foundation is a prominent, local leader in this field, and I am honored to take part in their efforts,” said Mark Melchiorre, Executive Managing Director, CIO & Head of Brean Investment Group and recipient of the SWCRF 2022 Finance Leader Award.

“I’ve had friends and family with cancer but because of incredible advancements in treatment there is always a light at the end of the tunnel. I’m proud to be a part of the Samuel Waxman Cancer Research Foundation’s fight to find a cure and end this disease once and for all,” said Chef Julian Medina, recipient of the SWCRF 2022 Hospitality and Service Award.

“Max Mara is honored to be partnering with the Samuel Waxman Cancer Research Foundation, an organization whose mission is to eliminate cancer through innovative and collaborative research. At Max Mara, we honor those who have been impacted by cancer and we are proud to help in the fight to free the world from this devastating disease,” Cristian Notari, CEO of Max Mara USA. Max Mara was the recipient of the SWCRF 2022 Fashion Cares Award.

Attendees enjoyed a night of delicious tastings from dozens of chefs, restaurants, and beverage companies such Chef Honoree Julian Medina’s Toloache, Coppelia, La Chula, and Tacuba; Arlotta Food Studio; Barney Greengrass; Centro Trattoria and Bar; Chef Peter Ambrose; Chef David Burke; Chef Harold Moore; Mercato Cucina; Phillipe Chow; T Bar; Tommy Bahama; Union Sushi & Steak; A La Mode Ice Cream Truck; Clarkson Avenue Crumb Cake Co.; Lilly’s Baking Company; Magnolia Bakery; and drinks from Herradura, Woodford Reserve, LoverBoy Hard Tea, Blood Monkey Gin, Palm Bay, Simple Vodka, Hampton Water, and Bridgehampton Breeze Wine to name just a few.

The event also featured a thrilling live auction facilitated by Heritage Auctions, entertainment by Josh Beckerman, aka The Foodie Magician, DJ Jetset and GR1FN.

Event sponsors include Gold Sponsor: Theodore A. Rapp Foundation; Bronze Sponsors: Erika and Mark Melchiorre; VIP Sponsors: Bess Freedman, The Fishel Family, Max Mara, Brown Harris Stevens and Dentons; Supporting Sponsors: Brown Pollock Charitable fund, Eurostruct Inc., Fabric to Finish, Olshan, and Hampton Racquet; Media Sponsors: Lawlor Media Group, Hamptons Magazine, James Lane Post, and Mann About Town.

Hamptons Happening event chair was Mark D. Friedman of Brown Harris Stevens with co-chairs, Jamie Koff, Fabric to Finish and Erica Fineberg. The event committee included Alexandra Adame, Chris Arlotta, Antonella Bertello, Timothy Burch, Natalie Cohen Gould, Jennifer Counihan, Maria Fishel, Jacqueline Frank, Michael Frank, Michelle Greenberg, Bryan Griffin, Dina Koutroumanis, Norah Lawlor, Jessica Mackin, Kristyn, Mazza, Pamela Morgan, April Murena, Lib Obeid, Christine Prydatko, Randi Schatz, Joshua Sechter, Michael Snell, and Tiffiany West.

The full gallery of event photographs is available to view online on Patrick McMullan, https://www.patrickmcmullan.com/events/62caf27ffdffca7669000001/ For Hi-Res versions of selected images, visit: https://bit.ly/3yU5YsX

About the Samuel Waxman Cancer Research Foundation (SWCRF): The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe. For more information about the SWCRF research, visit www.waxmancancer.org.

Facebook: WaxmanCancer https://www.facebook.com/WaxmanCancer Instagram: @waxmancancer https://www.instagram.com/waxmancancer/ Twitter: @waxmancancer https://twitter.com/WaxmanCancer

#18th ANNUAL HAMPTONS, #BENEFITTED, #SAMUEL WAXMAN, #CANCER, #RESEARCH , #FOUNDATION,  #HONORING, #BUSINESS, #FASHION, #CUISINE

The post 18th ANNUAL HAMPTONS HAPPENING BENEFITTED THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION HONORING LUMINARIES IN BUSINESS, FASHION, AND CUISINE appeared first on Good News!.